Mamento, Hanan S.

HRN: 11-46-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2023
CEFUROXIME 1.5GM (VIAL)
09/13/2023
09/20/2023
IVT
1.5 Gms
Now Then Q 8 Hrs
S/P LTCS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: